- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antibody targeting of claudin-1 as a potential colorectal cancer therapy ; volume:36 ; number:1 ; day:28 ; month:6 ; year:2017 ; pages:1-13 ; date:12.2017
Journal of experimental & clinical cancer research ; 36, Heft 1 (28.6.2017), 1-13, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Cherradi, S.
- Beteiligte Personen und Organisationen
-
Ayrolles-Torro, A.
Vezzo-Vié, N.
Gueguinou, N.
Denis, V.
Combes, E.
Boissière, F.
Busson, M.
Canterel-Thouennon, L.
Mollevi, C.
Pugnière, M.
Bibeau, F.
Ychou, M.
Martineau, P.
Gongora, C.
Del Rio, M.
SpringerLink (Online service)
- DOI
-
10.1186/s13046-017-0558-5
- URN
-
urn:nbn:de:1111-2017092212654
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cherradi, S.
- Ayrolles-Torro, A.
- Vezzo-Vié, N.
- Gueguinou, N.
- Denis, V.
- Combes, E.
- Boissière, F.
- Busson, M.
- Canterel-Thouennon, L.
- Mollevi, C.
- Pugnière, M.
- Bibeau, F.
- Ychou, M.
- Martineau, P.
- Gongora, C.
- Del Rio, M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
Structural and biophysical insights into targeting of claudin-4 by a synthetic antibody fragment
Targeting Claudin-18.2 for cancer therapy: updates from 2024 ASCO annual meeting
Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
Monoclonal antibody therapy
The role of antibody-dependent cellular cytotoxicity for IgG1 monoclonal antibody therapy of metastatic colorectal cancer
M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses
Multivalent antibody-scTRAIL fusion proteins for tumor therapy : impact of format and targeting
Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer
Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy
Generierung und Charakterisierung Claudin 16 und Claudin 10 defizienter Mäuse
A humanized 4-1BB-targeting agonistic antibody exerts potent antitumor activity in colorectal cancer without systemic toxicity
Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
Structural and biophysical insights into targeting of claudin-4 by a synthetic antibody fragment
Targeting Claudin-18.2 for cancer therapy: updates from 2024 ASCO annual meeting
Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
Monoclonal antibody therapy
The role of antibody-dependent cellular cytotoxicity for IgG1 monoclonal antibody therapy of metastatic colorectal cancer
M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses
Multivalent antibody-scTRAIL fusion proteins for tumor therapy : impact of format and targeting
Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer
Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy
Generierung und Charakterisierung Claudin 16 und Claudin 10 defizienter Mäuse
A humanized 4-1BB-targeting agonistic antibody exerts potent antitumor activity in colorectal cancer without systemic toxicity
Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
Structural and biophysical insights into targeting of claudin-4 by a synthetic antibody fragment
Targeting Claudin-18.2 for cancer therapy: updates from 2024 ASCO annual meeting
Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
Monoclonal antibody therapy
The role of antibody-dependent cellular cytotoxicity for IgG1 monoclonal antibody therapy of metastatic colorectal cancer
M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses
Multivalent antibody-scTRAIL fusion proteins for tumor therapy : impact of format and targeting
Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer
Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy
Generierung und Charakterisierung Claudin 16 und Claudin 10 defizienter Mäuse